Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $162,400 - $180,699
-777 Reduced 79.45%
201 $44,000
Q4 2023

Feb 12, 2024

SELL
$197.69 - $227.29 $18,385 - $21,137
-93 Reduced 8.68%
978 $223,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $26,538 - $29,264
-132 Reduced 10.97%
1,071 $216,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $4,874 - $5,550
-23 Reduced 1.88%
1,203 $291,000
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $25,385 - $30,681
119 Added 10.75%
1,226 $282,000
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $6,519 - $7,967
-32 Reduced 2.81%
1,107 $261,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $6,349 - $8,127
31 Added 2.8%
1,139 $234,000
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $236,956 - $307,879
1,108 New
1,108 $259,000
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $668 - $805
-4 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $453 - $729
4 New
4 $1,000
Q3 2019

Nov 12, 2019

SELL
$159.77 - $178.1 $1,437 - $1,602
-9 Closed
0 $0
Q2 2019

Aug 21, 2019

BUY
$144.16 - $172.9 $1,297 - $1,556
9 New
9 $2,000
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $2,597 - $3,282
-21 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $3,018 - $3,388
-18 Reduced 46.15%
21 $4,000
Q2 2018

Jul 25, 2018

SELL
$160.33 - $189.41 $6.65 Million - $7.86 Million
-41,488 Reduced 99.91%
39 $7,000
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $1.57 Million - $1.73 Million
-9,708 Reduced 18.95%
41,527 $6.72 Million
Q4 2017

Feb 09, 2018

SELL
$147.99 - $163.95 $110,104 - $121,978
-744 Reduced 1.43%
51,235 $8.17 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $7.77 Million - $8.35 Million
51,979
51,979 $7.85 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.